Pune’s Venture Center opens Center for Biopharma Analysis to support National Biopharma Mission

New Delhi: Pune-based technology business incubator, Venture Center, hosted by CSIR-National Chemical Laboratory will host the Center for Biopharma Analysis (CBA) to support the National Biopharma Mission (NBM) of the Government of India.

CBA will provide high-quality analytical services for biopharmaceutical developers and manufacturers. CBA aims to be recognized as a ‘one-stop shop’ GLP facility for structural and functional characterization of biotherapeutics. NBM plans to make that possible by funding creation of a supportive ecosystem and leveraging the capabilities of organizations like Venture Center. We envision this center to become a resource center for biopharma characterization that will create long lasting value for bioentrepreneur and industry.

Inaugurating the facility via video conference, Dr Renu Swarup, Secretary, Department of Biotechnology, said  that she expects that the CBA will play an important role in supporting biopharma innovations from academic and government research labs, startups and many Indian companies with not only high quality analytical characterization but also advise on studies needed for regulatory approvals. This can help speed up the development process.

Also speaking on the occasion, Prof AK Nangia, Director, CSIR-NCL highlighted how NCL is keen to contribute to the large molecule therapeutics revolution waiting to happen in India as it did for small molecule therapeutics in 1970-80s.  Mr Prasanta Biswal, CEO of International Biotech Park Limited, Pune said that IBPL is happy to have contributed CSR support for the CBA infrastructure development and looks forward to working closely with Venture Center and BIRAC in positioning the Pune Knowledge Cluster for excellence in biopharma and medtech development and manufacturing. The program was followed by a motivational talk by Dr. Himanshu Gadgil, CSO, Enzene Biosciences, Pune on ‘Era of Biopharmaceuticals- India perspective’.